Role of c-jun expression increased by heat shock- and ceramide-activated caspase-3 in HL-60 cell apoptosis -: Possible involvement of ceramide in heat shock-induced apoptosis

被引:75
作者
Kondo, T
Matsuda, T
Kitano, T
Takahashi, A
Tashima, M
Ishikura, H
Umehara, H
Domae, N
Uchiyama, T
Okazaki, T
机构
[1] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Sakyo Ku, Kyoto 6068507, Japan
[2] Osaka Den Univ, Dept Med, Cyuo Ku, Osaka 5400008, Japan
[3] Shimane Med Univ, Transfus Div, Izumo, Shimane 6930027, Japan
关键词
D O I
10.1074/jbc.275.11.7668
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ceramide has emerged as a lipid mediator in apoptosis induced by a variety of stresses. As we previously showed that the activation of AP-I, a nuclear transcription factor was indispensable to ceramide-induced apoptosis in human leukemia HL-60 cells (Sawai, H, Okazaki, T., Yamamoto, H., Okano, H., Takeda, Y., Tashima, M., Sawada, H., Okuma, M., Ishikura, H., Umehara, M., and Domae, N. (1995) J. Biol. Chem, 270, 27326-27331), the role and mechanism of heat shock (HS)-increased c-jun expression in apoptosis was here investigated. KS increased morphological changes compatible with apoptosis in human leukemia HL-60 cells, and induced ceramide generation and sphingomyelin hydrolysis with an increase of neutral magnesium-dependent sphingomyelinase activity. When MS failed to induce apoptosis in MS-resistant HL-60 cells, ceramide generation was not detected, suggesting that ceramide was involved in downstream signals required for MS-induced apoptosis. Both MS and N-acetylsphingosine (C-2-ceramide) increased the expression of c-jun/c-fos mRNAs with the peak 2 h after treatment. When we examined whether the inhibition of c-jun expression by its antisense oligodeoxynucleotides (AS) blocked HS- or C-2-ceramide-induced apoptosis, AS of c-jun gene inhibited apoptotic morphological changes and DNA fragmentation whereas did not sense oligodeoxynucleotides. Moreover, a synthetic tetrapeptide, acetyl-Asp-Met-Gln-Asp-aldehyde (DMQD-CRO), which inhibited the formation of active form of caspase-3 more efficiently than those of caspase-4, -6, -7, and -8, blocked both caspase-3 like activity, c-jun expression and apoptosis induced by MS or C,-ceramide, although DMQD-CHO did not affect HS-induced ceramide generation. These results suggested that the ceramide was generated through sphingomyelin hydrolysis by MS-activated neutral, magnesiun-dependent sphingomyelinase and that subsequent c-jun expression through activation of caspase-3 played a role in MS-induced ML-60 cell apoptosis.
引用
收藏
页码:7668 / 7676
页数:9
相关论文
共 45 条
[21]   Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking Caspase 9 [J].
Kuida, K ;
Haydar, TF ;
Kuan, CY ;
Gu, Y ;
Taya, C ;
Karasuyama, H ;
Su, MSS ;
Rakic, P ;
Flavell, RA .
CELL, 1998, 94 (03) :325-337
[22]   Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice [J].
Kuida, K ;
Zheng, TS ;
Na, SQ ;
Kuan, CY ;
Yang, D ;
Karasuyama, H ;
Rakic, P ;
Flavell, RA .
NATURE, 1996, 384 (6607) :368-372
[23]   CLEAVAGE OF POLY(ADP-RIBOSE) POLYMERASE BY A PROTEINASE WITH PROPERTIES LIKE ICE [J].
LAZEBNIK, YA ;
KAUFMANN, SH ;
DESNOYERS, S ;
POIRIER, GG ;
EARNSHAW, WC .
NATURE, 1994, 371 (6495) :346-347
[24]   PROTOONCOGENES OF THE FOS/JUN FAMILY OF TRANSCRIPTION FACTORS ARE POSITIVE REGULATORS OF MYELOID DIFFERENTIATION [J].
LORD, KA ;
ABDOLLAHI, A ;
HOFFMANLIEBERMANN, B ;
LIEBERMANN, DA .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (02) :841-851
[25]  
LOTEM J, 1993, CELL GROWTH DIFFER, V4, P41
[26]   ASPARTATE-BASED INHIBITOR OF INTERLEUKIN-1-BETA-CONVERTING ENZYME PREVENTS ANTITUMOR AGENT-INDUCED APOPTOSIS IN HUMAN MYELOID-LEUKEMIA U937 CELLS [J].
MASHIMA, T ;
NAITO, M ;
KATAOKA, S ;
KAWAI, H ;
TSURUO, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 209 (03) :907-915
[27]   Small stress proteins as novel regulators of apoptosis - Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death [J].
Mehlen, P ;
SchulzeOsthoff, K ;
Arrigo, AP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16510-16514
[28]  
Noguchi K, 1996, ONCOGENE, V13, P39
[29]  
OKAZAKI T, 1989, J BIOL CHEM, V264, P19076
[30]  
OKAZAKI T, 1990, J BIOL CHEM, V265, P15823